Washington University School of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).

1,502 total trials 214 currently recruiting 919 completed early-phase tilt top decile by trial count

Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.

Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.

Top-decile sponsor footprint

Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 38/100

919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,502 total, page 11 of 31

COMPLETED NA

Determining Effectiveness of an mHealth Intervention to Provide Adolescent CBT

NCT04603053
COMPLETED NA

Aging With Long Term Physical Disabilities

NCT04589988
COMPLETED NA

Implementing BREASTChoice Into Practice

NCT04491591
COMPLETED NA

Tourniquet on Total Knee Arthroplasty

NCT04923724
COMPLETED NA

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

NCT04366440
COMPLETED Phase 4

Ketamine for Older Adults Pilot

NCT04504175
COMPLETED Phase 2

Duvelisib to Combat COVID-19

NCT04372602
TERMINATED Phase 2

Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

NCT04373369
TERMINATED Early Phase 1

CCR2 AAA Pilot Study

NCT04592991
COMPLETED NA

Effect of NMN Supplementation on Organ System Biology

NCT04571008
COMPLETED NA

Palliative Expeditiously Adaptive Quad Shot Radiation Therapy (PEAQ-RT)

NCT04379505
COMPLETED NA

CoV-PICS: A Virtual Post-ICU Clinic

NCT04490278
COMPLETED Phase 3

Management of Post-Tonsillectomy Pain in Pediatric Patients

NCT04551196
COMPLETED NA

Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers

NCT04553471
COMPLETED

Remote Collection of Patient Reported Toxicity Using SMS Text Messaging (CareSignal)

NCT04437472
COMPLETED NA

The Emergency Department Sedation Pilot Trial

NCT04410783
TERMINATED Phase 1

Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer

NCT03982004
COMPLETED Phase 3

CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION

NCT04333732
COMPLETED

Active Symptom Monitoring in Patients Undergoing Radiation Therapy for Thoracic Malignancies

NCT04324645
TERMINATED NA

Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT

NCT04685798
COMPLETED Phase 1

Auditory Training and Hearing Aid Satisfaction

NCT04230876
COMPLETED NA

Interactive Self-Management Augmented by Rehabilitation Technologies

NCT04743037
COMPLETED NA

Wellness Through Mobile Health

NCT04640090
COMPLETED Phase 1

Intra-arterial Chemotherapy for Retinoblastoma

NCT04342572
COMPLETED Early Phase 1

Radical Openness for Adolescents Pilot

NCT05913557
COMPLETED

Mechanomyography for Predictor of Prognosis in CuTS and PND Patients

NCT04322448
COMPLETED Phase 4

Safety of Reduced Infliximab Infusion Time

NCT05340764
TERMINATED Phase 2

Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)

NCT04267120
COMPLETED NA

Interactive Obesity Treatment Approach for Obesity Prevention in Adults With Early Serious Mental Illness: iOTA-SMI

NCT03980743
COMPLETED NA

De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer

NCT04386993
TERMINATED

Long Term Function Outcomes and Pain in Implant-based Post-mastectomy Breast Reconstruction

NCT04477538
COMPLETED NA

Clinic to Community Connections - Broader Distribution

NCT04474795
COMPLETED

SPINCOMS Biomarker Study

NCT04496830
COMPLETED NA

Cost Talk: Discussing Cancer Care Costs

NCT04397016
TERMINATED Phase 2

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation

NCT06424236
COMPLETED NA

Using Interventional Informatics to Address Social Determinants of Health During Clinical Care Visits to Promote Behavior Change and PREVENT Cardiovascular Disease

NCT06121193
TERMINATED NA

PET/MR for Rectal Cancer Treatment Monitoring and Surveillance

NCT04150705
TERMINATED NA

Gated and Non-Gated Dynamic PET/CT Imaging

NCT04283552
COMPLETED NA

Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity

NCT04314284
COMPLETED

Needs of Persons with Spinal Cord Injury (SCI)

NCT04422769
COMPLETED

Evaluation of Antibody Tests for COVID-19

NCT04360954
COMPLETED

Thin and Ultrathin Bronchoscopy With Transbronchial Needle Aspiration and Radial Probe Endobronchial Ultrasound for Peripheral Pulmonary Lesions

NCT04331587
COMPLETED Phase 2

Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas

NCT03532295
COMPLETED Phase 2

A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection

NCT04342663
COMPLETED Phase 1

Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation

NCT04131738
TERMINATED Phase 3

Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection

NCT04341727
TERMINATED Phase 1

Isatuximab, Bendamustine, and Prednisone in Refractory Multiple Myeloma

NCT04083898
COMPLETED NA

Interventions to Help More Low-income Smokers Quit

NCT04311983
TERMINATED Early Phase 1

WU 345: Immune Responses to Adjuvanted and Non-adjuvanted Seasonal Influenza Vaccines in the Lymphoid Tissues.

NCT07386509
COMPLETED NA

Sing for Your Saunter

NCT04246476
← Previous Page 11 of 31 Next →

Phase Distribution

PhaseTrial count
Phase 1 332
Phase 2 237
Phase 3 40
Phase 4 58

Therapeutic Areas

Obesity 20
Breast Cancer 19
Multiple Myeloma 13
Myelodysplastic Syndromes 13
Alzheimer Disease 10
Parkinson Disease 8
Depression 8
Cancer of the Breast 7
Dementia 7
Insulin Resistance 7

What is open in the Washington University School of Medicine pipeline

214 recruiting of 1,502 indexed (14% open); 919 completed (61%).

Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).

Top condition: Obesity (20 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Washington University School of Medicine: open-pipeline peers nationwide

Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20% Total trials Recruiting share Washington University School of MedicineYale UniversityJohns Hopkins UniversityUniversity of PennsylvaniaNovartis PharmaceuticalsAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,502 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Washington University School of Medicine page

1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.

  • 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.